Document is current
Any future updates will be listed below
-
Authors
Al Musawa, Mohammed
El Ghali, Amer
Morrisette, Taylor
Banks, Andrea L.
Saeedi, Mohammed
Mahoney, Monica
Salam, Madison
Sinclair, Emily
Chen, Brandon
Molina, Kyle C.
Thomas, Michael
Zeuli, John
Webb, Andrew J.
Holger, Dana J.
Tupayachi-Ortiz, Maria G.
Bouchard, Jeannette
Veve, Michael P.
Eubank, Taryn A.
Raja, Karan
Campion, Maureen
Stevens, Ryan W.
Rybak, Michael J.
-
Funding
Funding for this research was provided by:
Paratek Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Received: 21 January 2026
Accepted: 7 April 2026
First Online: 25 May 2026
Declarations
Human ethics and consent to participate: This retrospective study utilized de-identified patient data and involved no direct interaction with study participants. The requirement for informed consent was waived by the Institutional Review Board due to the nature of the study. Ethical approval was obtained from the Institutional Review Board at Wayne State University (090219M1X, protocol number 1908002459) as well as from the review boards of all participating institutions. Clinical trial number: not applicable. The study was conducted in accordance with the principles of the Declaration of Helsinki.
Competing interests: MJR received funding from Paratek Pharmaceuticals Inc. as an unrestricted investigator-initiated study.
